Join Today!

Become a member and connect with:

An Active Online Community
Articles and Advice on SCD
Help Understanding Clinical Trials

healthcare providers

Winfred C. Wang, MD

Healthcare Provider
Member Emeritus
St. Jude Children's Research Hospital
MS 800, Room R5036
262 Danny Thomas Place
Memphis, Tennessee, United States

Dr. Winfred Wang is a pediatric hematologist-oncologist in Memphis, Tennessee and is affiliated with multiple hospitals in the area, including Methodist Hospitals of Memphis and St. Jude Children’s Research Hospital. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice for more than 20 years.

Research Interests:
– Sickle cell disease and other hemoglobinopathies
– Aplastic anemia and other disorders of bone marrow failure
– Neutropenia and granulocyte colony-stimulating factor (G-CSF)

Representative Publications:

Clinic Attendance of Youth With Sickle Cell Disease on Hydroxyurea Treatment

Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia

Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study

Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke

Hydroxyurea and growth in young children with sickle cell disease

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease

view full profile